Evoke Pharma
EVOK
EVOK
10 hedge funds and large institutions have $3.45M invested in Evoke Pharma in 2014 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 1 closing their positions.
Holders
10
Holders Change
+3
Holders Change %
+42.86%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
2
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
1
Morgan Stanley
New York
|
$4K |
| 2 |
ARTA
2
A.R.T. Advisors
New York
|
$0 |
| 3 |
TC
3
TFS Capital
West Chester,
Pennsylvania
|
$88K |
| 4 |
4
Bank of America
Charlotte,
North Carolina
|
$281K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
OM
1
Opaleye Management
Boston,
Massachusetts
| $1.96M | 233,400 | +233,400 | New |
|
|
SC
2
Sophrosyne Capital
New York
| $411K | 49,000 | +49,000 | New |
|
3
Vanguard Group
Malvern,
Pennsylvania
| $395K | 47,394 | +11,173 | +31% |
|
|
4
Bank of America
Charlotte,
North Carolina
| $281K | 33,500 | -1,029 | -3% |
|
|
LP
5
LMR Partners
London,
United Kingdom
| $199K | 23,882 | +23,882 | New |
|
|
TC
6
TFS Capital
West Chester,
Pennsylvania
| $88K | 10,556 | -4,187 | -28% |
|
7
Geode Capital Management
Boston,
Massachusetts
| $85K | 10,276 | +10,276 | New |
|
8
Citigroup
New York
| $17K | 2,086 | +2,086 | New |
|
|
U
9
UBS
Zurich,
Switzerland
| $11K | 1,320 | +467 | +55% |
|
|
10
Morgan Stanley
New York
| $4K | 500 | -17,879 | -97% |
|
|
ARTA
11
A.R.T. Advisors
New York
| – | – | -11,204 | Closed |
|